USD 163.5
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| CRL | -1.4 | -11.1 | -13.6 | -17.3 | -26.7 | -19.7 | -51.9 | 2.3 | 139.9 | 643.2 |
| S&P 500 | 1.0 | 1.8 | -0.9 | 2.7 | 7.3 | 26.5 | 31.0 | 80.1 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | CRL |
| name | Charles River Laboratories International, Inc. |
| price | 163.5 |
| changes percentage | -1.3872 |
| change | -2.3 |
| day low | 163.08 |
| day high | 167.5 |
| year high | 275 |
| year low | 160.85 |
| market cap | 8360768700 |
| price avg 50 | 192.4206 |
| price avg 200 | 207.3246 |
| exchange | NYSE |
| volume | 769686 |
| avg volume | 738978 |
| open | 165.41 |
| previous close | 165.8 |
| eps | 8.02 |
| pe | 20.39 |
| earnings announcement | 2025-02-12T13:30:00.000+0000 |
| shares outstanding | 51136200 |
| timestamp | 2025-01-17 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001100682 | |||
| revenue | 4129409000 | 3976060000 | 3.86 |
| gross profit | 1502556000 | 1462651000 | 2.73 |
| gross profit ratio | 0.36 | 0.37 | -1.09 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 816386000 | 811676000 | 0.58 |
| interest income | 5196000 | 780000 | 566.15 |
| interest expense | 136710000 | 59291000 | 130.57 |
| ebitda | 1032118000 | 1035860000 | -0.36 |
| ebitdaratio | 0.25 | 0.25 | 0.77 |
| operating income | 617261000 | 650975000 | -5.18 |
| operating income ratio | 0.15 | 0.16 | -8.70 |
| net income | 474624000 | 486226000 | -2.39 |
| net income ratio | 0.11 | 0.12 | -6.01 |
| eps | 9.27 | 9.57 | -3.13 |
Revenue Growth: revenue increased to 4,129 million in 2023 from 3,976 million in 2022 representing a change of 3.86%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 1,503 million in 2023 from 1,463 million in 2022 representing a change of 2.73%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses increased to 816 million in 2023 from 812 million in 2022 representing a change of 0.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,032 million in 2023 from 1,036 million in 2022 representing a change of -0.36%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 617 million in 2023 from 651 million in 2022 representing a change of -5.18%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 475 million in 2023 from 486 million in 2022 representing a change of -2.39%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 9.27 in 2023 from 9.27 in 2022 representing a change of -3.13%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001100682 | |||
| revenue | 1009763000 | 1026117000 | -1.59 |
| gross profit | 349021000 | 335462000 | 4.04 |
| gross profit ratio | 0.35 | 0.33 | 5.73 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 199213000 | 165855000 | 20.11 |
| interest income | 1528000 | 3010000 | -49.24 |
| interest expense | 30284000 | 32769000 | -7.58 |
| ebitda | 209723000 | 238504000 | -12.07 |
| ebitdaratio | 0.21 | 0.25 | -16.65 |
| operating income | 117405000 | 169607000 | -30.78 |
| operating income ratio | 0.12 | 0.17 | -29.66 |
| net income | 68679000 | 89988000 | -23.68 |
| net income ratio | 0.07 | 0.09 | -22.44 |
| eps | 1.34 | 1.75 | -23.43 |
Revenue Growth: revenue decreased to 1,010 million in 2024Q3 from 1,026 million in 2024Q2 representing a change of -1.59%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 199 million in 2024Q3 from 166 million in 2024Q2 representing a change of 20.11%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 210 million in 2024Q3 from 239 million in 2024Q2 representing a change of -12.07%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 117 million in 2024Q3 from 170 million in 2024Q2 representing a change of -30.78%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 69 million in 2024Q3 from 90 million in 2024Q2 representing a change of -23.68%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 1.34 in 2024Q3 from 1.34 in 2024Q2 representing a change of -23.43%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Gross Profit: Gross Profit increased to 349 million in 2024Q3 from 335 million in 2024Q2 representing a change of 4.04%. This indicates a sales profitability growth, which is a positive sign for the company.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001100682 | |||
| total assets | 8195001000 | 7602770000 | 7.79 |
| total liabilities | 4536003000 | 4579265000 | -0.94 |
| total equity | 3658998000 | 3023505000 | 21.02 |
| cash and cash equivalents | 276771000 | 233912000 | 18.32 |
| short term investments | 0 | 998000 | -100.00 |
| long term investments | 243811000 | 311602000 | -21.76 |
| total current assets | 1608662000 | 1439032000 | 11.79 |
| total non current assets | 6586339000 | 6163738000 | 6.86 |
| total current liabilities | 1055082000 | 1091585000 | -3.34 |
| total non current liabilities | 3480921000 | 3487680000 | -0.19 |
| common stock | 513000 | 509000 | 0.79 |
| retained earnings | 1887218000 | 1432901000 | 31.71 |
| total debt | 3066381000 | 3097276000 | -1.00 |
Total Assets: Total Assets increased to 8,195 million in 2023 from 7,603 million in 2022 representing a change of 7.79%. Suggesting a growth in asset holdings.
Total Liabilities: Total Liabilities decreased to 4,536 million in 2023 from 4,579 million in 2022 representing a change of -0.94%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 3,659 million in 2023 from 3,024 million in 2022 representing a change of 21.02%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 277 million in 2023 from 234 million in 2022 representing a change of 18.32%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 1,609 million in 2023 from 1,439 million in 2022 representing a change of 11.79%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 1,055 million in 2023 from 1,092 million in 2022 representing a change of -3.34%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 0.79%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to 1,887 million in 2023 from 1,433 million in 2022 representing a change of 31.71%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 3,066 million in 2023 from 3,097 million in 2022 representing a change of -1.0%. This indicates a reduction in overall debt burden.
Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 1 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001100682 | |||
| total assets | 8003842000 | 7948283000 | 0.70 |
| total liabilities | 4176125000 | 4175189000 | 0.02 |
| total equity | 3822863000 | 3773094000 | 1.32 |
| cash and cash equivalents | 210171000 | 179538000 | 17.06 |
| short term investments | 0 | 0 | NaN |
| long term investments | 235987000 | 233325000 | 1.14 |
| total current assets | 1494723000 | 1499273000 | -0.30 |
| total non current assets | 6509119000 | 6449010000 | 0.93 |
| total current liabilities | 1012221000 | 947519000 | 6.83 |
| total non current liabilities | 3163904000 | 3227670000 | -1.98 |
| common stock | 517000 | 517000 | 0.00 |
| retained earnings | 2122835000 | 2053556999 | 3.37 |
| total debt | 2759489000 | 2841180000 | -2.88 |
Total Assets: Total Assets increased to 8,004 million in 2024Q3 from 7,948 million in 2024Q2 representing a change of 0.7%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 3,823 million in 2024Q3 from 3,773 million in 2024Q2 representing a change of 1.32%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 210 million in 2024Q3 from 180 million in 2024Q2 representing a change of 17.06%. This indicates an increase in available liquid assets.
Retained Earnings: Retained Earnings increased to 2,123 million in 2024Q3 from 2,054 million in 2024Q2 representing a change of 3.37%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 2,759 million in 2024Q3 from 2,841 million in 2024Q2 representing a change of -2.88%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 4,176 million in 2024Q3 from 4,175 million in 2024Q2 representing a change of 0.02%. This indicates an increase in overall liabilities.
Total Current Assets: Total Current Assets decreased to 1,495 million in 2024Q3 from 1,499 million in 2024Q2 representing a change of -0.3%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 1,012 million in 2024Q3 from 948 million in 2024Q2 representing a change of 6.83%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001100682 | |||
| net change in cash | 43266000 | -5100000 | 948.35 |
| operating cash flow | 683898000 | 619640000 | 10.37 |
| free cash flow | 365370000 | 294907000 | 23.89 |
| capital expenditure | -318528000 | -324733000 | 1.91 |
| depreciation and amortization | 314124000 | 303870000 | 3.37 |
| deferred income tax | -50903000 | -35884000 | -41.85 |
| stock based compensation | 72048000 | 73617000 | -2.13 |
| accounts payables | -20427000 | -2652000 | -670.25 |
| inventory | -62301000 | -78523000 | 20.66 |
| acquisitions net | -194785000 | -120117000 | -62.16 |
| investments in property plant and equipment | -318528000 | -324733000 | 1.91 |
| net cash used for investing activites | -563155000 | -607922000 | 7.36 |
| debt repayment | -75323000 | 19794000 | -480.53 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -24155000 | -38651000 | 37.50 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -85521000 | -42397000 | -101.71 |
| cash at end of period | 284480000 | 241214000 | 17.94 |
| accounts receivables | -33434000 | -150570000 | 77.80 |
| cash at beginning of period | 241214000 | 246314000 | -2.07 |
Net Change in Cash: Net Change in Cash increased to 43 million in 2023 from -5 million in 2022 representing a change of 948.35%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 684 million in 2023 from 620 million in 2022 representing a change of 10.37%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 365 million in 2023 from 295 million in 2022 representing a change of 23.89%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 72 million in 2023 from 74 million in 2022 representing a change of -2.13%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Capital Expenditure: Capital Expenditure increased to -319 million in 2023 from -325 million in 2022 representing a change of 1.91%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Accounts Payables: The absolute value of Accounts Payables increased to 20 million in 2023 from 3 million in 2022 representing a change of -670.25%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to -33 in 2023 from -151 million in 2022 representing a change of 77.8%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001100682 | |||
| operating cash flow | 251792000 | 193535000 | 30.10 |
| free cash flow | 213071000 | 154049000 | 38.31 |
| capital expenditure | -38721000 | -39486000 | 1.94 |
| depreciation and amortization | 88198000 | 86082000 | 2.46 |
| deferred income tax | -12915000 | -12086000 | -6.86 |
| stock based compensation | 19331000 | 16587000 | 16.54 |
| accounts receivables | 17228000 | 18353000 | -6.13 |
| accounts payables | -659000 | 2105000 | -131.31 |
| inventory | 4039000 | 4150000 | -2.67 |
| acquisitions net | 0 | -5479000 | 100.00 |
| investments in property plant and equipment | -38721000 | -39486000 | 1.94 |
| net cash used for investing activites | -21324000 | -61866000 | 65.53 |
| debt repayment | -94063000 | -254544000 | 63.05 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -100786000 | -8914000 | -1030.65 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -207536000 | -285858000 | 27.40 |
| net change in cash | 32102000 | -157828000 | 120.34 |
| cash at end of period | 211640000 | 179538000 | 17.88 |
| cash at beginning of period | 179538000 | 337366000 | -46.78 |
Net Change in Cash: Net Change in Cash increased to 32 million in 2024Q3 from -158 million in 2024Q2 representing a change of 120.34%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 252 million in 2024Q3 from 194 million in 2024Q2 representing a change of 30.1%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 213 million in 2024Q3 from 154 million in 2024Q2 representing a change of 38.31%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024Q3 from 2 million in 2024Q2 representing a change of -131.31%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 17 million in 2024Q3 from 18 million in 2024Q2 representing a change of -6.13%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Capital Expenditure: Capital Expenditure increased to -39 million in 2024Q3 from -39 million in 2024Q2 representing a change of 1.94%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 19 million in 2024Q3 from 17 million in 2024Q2 representing a change of 16.54%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-30 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 80.61 | 78.25 | 3.02 |
| net income per share | 9.27 | 9.57 | -3.18 |
| operating cash flow per share | 13.35 | 12.19 | 9.48 |
| free cash flow per share | 7.13 | 5.8 | 22.89 |
| cash per share | 5.4 | 4.62 | 16.87 |
| book value per share | 71.43 | 59.5 | 20.04 |
| tangible book value per share | -5.86 | -15.38 | 61.92 |
| shareholders equity per share | 70.21 | 58.57 | 19.87 |
| interest debt per share | 62.53 | 62.12 | 0.65 |
| market cap | 12110062800 | 11071934800 | 9.38 |
| enterprise value | 14899672800 | 13935298800 | 6.92 |
| pe ratio | 25.52 | 22.77 | 12.05 |
| price to sales ratio | 2.93 | 2.78 | 5.31 |
| pocfratio | 17.71 | 17.87 | -0.90 |
| pfcf ratio | 33.14 | 37.54 | -11.72 |
| pb ratio | 3.37 | 3.72 | -9.50 |
| ptb ratio | 3.37 | 3.72 | -9.50 |
| ev to sales | 3.61 | 3.5 | 2.95 |
| enterprise value over ebitda | 14.44 | 13.45 | 7.31 |
| ev to operating cash flow | 21.79 | 22.49 | -3.13 |
| ev to free cash flow | 40.78 | 47.25 | -13.70 |
| earnings yield | 0.04 | 0.04 | -10.75 |
| free cash flow yield | 0.03 | 0.03 | 13.27 |
| debt to equity | 0.85 | 1.04 | -18.08 |
| debt to assets | 0.37 | 0.41 | -8.15 |
| net debt to ebitda | 2.7 | 2.76 | -2.22 |
| current ratio | 1.52 | 1.32 | 15.66 |
| interest coverage | 4.52 | 10.98 | -58.88 |
| income quality | 1.42 | 1.26 | 13.18 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.48 | 0.5 | -3.47 |
| capex to operating cash flow | 0.47 | 0.52 | -11.13 |
| capex to revenue | 0.08 | 0.08 | -5.55 |
| capex to depreciation | 1.01 | 1.07 | -5.11 |
| stock based compensation to revenue | 0.02 | 0.02 | -5.77 |
| graham number | 120.98 | 112.3 | 7.73 |
| roic | 0.07 | 0.08 | -8.93 |
| return on tangible assets | 0.11 | 0.13 | -12.49 |
| graham net net | -68.01 | -71.88 | 5.38 |
| working capital | 553580000 | 347447000 | 59.33 |
| tangible asset value | -300098000 | -781673000 | 61.61 |
| net current asset value | -2927341000 | -3140233000 | 6.78 |
| invested capital | 6546446000 | 6010042000 | 8.93 |
| average receivables | 766382500 | 697635500 | 9.85 |
| average payables | 187426000 | 202022500 | -7.23 |
| average inventory | 318034000 | 227477500 | 39.81 |
| days sales outstanding | 68.98 | 69.07 | -0.13 |
| days payables outstanding | 23.47 | 29.9 | -21.50 |
| days of inventory on hand | 52.84 | 37.15 | 42.23 |
| receivables turnover | 5.29 | 5.28 | 0.13 |
| payables turnover | 15.55 | 12.21 | 27.39 |
| inventory turnover | 6.91 | 9.83 | -29.69 |
| roe | 0.13 | 0.16 | -19.23 |
| capex per share | 6.22 | 6.39 | -2.71 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 25.52 on 2023-12-30 from 22.77 on 2022-12-31, representing a change of 12.05%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.52 on 2023-12-30 from 1.32 on 2022-12-31, representing a change of 15.66%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.85 on 2023-12-30 from 1.04 on 2022-12-31, representing a change of -18.08%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-28 Q3 | 2024-06-29 Q2 | Q/Q change % | |
|---|---|---|---|
| CRL | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 19.65 | 19.9 | -1.29 |
| net income per share | 1.34 | 1.75 | -23.45 |
| operating cash flow per share | 4.9 | 3.75 | 30.50 |
| free cash flow per share | 4.15 | 2.99 | 38.74 |
| cash per share | 4.09 | 3.48 | 17.42 |
| book value per share | 74.48 | 73.19 | 1.76 |
| tangible book value per share | -1.47 | -2.07 | 29.20 |
| shareholders equity per share | 73.59 | 72.21 | 1.91 |
| interest debt per share | 54.28 | 55.75 | -2.63 |
| market cap | 10191944140 | 10649405580 | -4.30 |
| enterprise value | 12741262140 | 13311047580 | -4.28 |
| pe ratio | 37.1 | 29.59 | 25.40 |
| price to sales ratio | 10.09 | 10.38 | -2.75 |
| pocfratio | 40.48 | 55.03 | -26.44 |
| pfcf ratio | 47.83 | 69.13 | -30.81 |
| pb ratio | 2.69 | 2.86 | -5.80 |
| ptb ratio | 2.69 | 2.86 | -5.80 |
| ev to sales | 12.62 | 12.97 | -2.73 |
| enterprise value over ebitda | 60.75 | 55.81 | 8.86 |
| ev to operating cash flow | 50.6 | 68.78 | -26.43 |
| ev to free cash flow | 59.8 | 86.41 | -30.80 |
| earnings yield | 0.01 | 0.01 | -20.25 |
| free cash flow yield | 0.02 | 0.01 | 44.52 |
| debt to equity | 0.73 | 0.76 | -4.40 |
| debt to assets | 0.34 | 0.36 | -3.55 |
| net debt to ebitda | 12.16 | 11.16 | 8.92 |
| current ratio | 1.48 | 1.58 | -6.68 |
| interest coverage | 3.88 | 5.18 | -25.10 |
| income quality | 3.58 | 2.15 | 66.55 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.49 | 0.49 | -0.10 |
| capex to operating cash flow | 0.15 | 0.2 | -24.63 |
| capex to revenue | 0.04 | 0.04 | -0.35 |
| capex to depreciation | 0.44 | 0.46 | -4.29 |
| stock based compensation to revenue | 0.02 | 0.02 | 18.43 |
| graham number | 47.04 | 53.26 | -11.67 |
| roic | 0.01 | 0.02 | -32.18 |
| return on tangible assets | 0.02 | 0.02 | -24.28 |
| graham net net | -62.89 | -63.03 | 0.23 |
| working capital | 482502000 | 551754000 | -12.55 |
| tangible asset value | -75336000 | -106728000 | 29.41 |
| net current asset value | -2681402000 | -2675916000 | -0.21 |
| invested capital | 6410666000 | 6431618000 | -0.33 |
| average receivables | 758214000 | 774600500 | -2.12 |
| average payables | 134532000 | 131391499.5 | 2.39 |
| average inventory | 342655500 | 355196000 | -3.53 |
| days sales outstanding | 67.22 | 66.85 | 0.55 |
| days payables outstanding | 18.52 | 17.34 | 6.77 |
| days of inventory on hand | 45.79 | 45.49 | 0.66 |
| receivables turnover | 1.34 | 1.35 | -0.55 |
| payables turnover | 4.86 | 5.19 | -6.34 |
| inventory turnover | 1.97 | 1.98 | -0.66 |
| roe | 0.02 | 0.02 | -24.88 |
| capex per share | 0.75 | 0.77 | -1.64 |
ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-28 Q3 from 0.02 on 2024-06-29 Q2, representing a change of -24.88%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 37.10 on 2024-09-28 Q3 from 29.59 on 2024-06-29 Q2, representing a change of 25.40%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.73 on 2024-09-28 Q3 from 0.76 on 2024-06-29 Q2, representing a change of -4.40%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Current Ratio: Current Ratio decreased to 1.48 on 2024-09-28 Q3 from 1.58 on 2024-06-29 Q2, representing a change of -6.68%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Positive Sentiment: Discounted Cash Flow value is 180.27 which is higher than current price 163.5, indicates the company may be undervalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-17 07:16:08
Charles River and Akron Bio collaborate to boost operations by integrating CGMP materials into the Cell Therapy Platform.
Sentiment: Positive
Publish Date: 2025-01-02 08:30:28
CRL's solid prospects in the RMS segment and solid financial stability create a favorable outlook for investors.
Sentiment: Negative
Publish Date: 2024-12-17 09:25:40
The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR-mutated non-small cell lung cancer.
Sentiment: Neutral
Publish Date: 2024-12-09 06:49:31
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Sentiment: Positive
Publish Date: 2024-12-06 09:06:11
Charles River's new initiative specifically caters to early-stage biotechnology developers.
Sentiment: Positive
Publish Date: 2024-12-05 08:00:00
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase-appropriate manufacturing of advanced therapies. “The Charles River Incubator Program launch, through our Global Innovation Center of Excellence, demonstrates a continued commitment to the global biotechnology industry by offeri.
Sentiment: Positive
Publish Date: 2024-11-28 08:21:20
Investors are optimistic about CRL stock due to its strong RMS prospects and inorganic growth efforts.
Sentiment: Positive
Publish Date: 2024-11-11 10:20:49
Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Sentiment: Positive
Publish Date: 2024-11-06 18:51:02
Charles River Laboratories International, Inc. (NYSE:CRL ) Q3 2024 Earnings Conference Call November 6, 2024 9:30 AM ET Company Participants Todd Spencer - Corporate Vice President of Investor Relations James Foster - President and Chief Executive Officer Flavia Pease - Chief Financial Officer Conference Call Participants Max Smock - William Blair & Company Matthew Sykes - Goldman Sachs David Windley - Jefferies Group LLC Eric Coldwell - Robert W. Baird & Co. Justin Bowers - Deutsche Bank Dan Leonard - UBS Group AG Elizabeth Anderson - Evercore ISI Michael Ryskin - BofA Securities, Inc. Tejas Savant - Morgan Stanley Casey Woodring - JPMorgan Chase & Co. Luke Sergott - Barclays Patrick Donnelly - Citigroup Inc. Operator Please stand by, we're about to begin.
Sentiment: Positive
Publish Date: 2024-11-06 13:01:18
CRL's organic revenue growth in the Manufacturing Solutions and RMS segments is more than offset by lower revenues in the DSA segment.
Sentiment: Positive
Publish Date: 2024-11-06 10:35:40
Although the revenue and EPS for Charles River (CRL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sentiment: Positive
Publish Date: 2024-11-06 09:10:47
Charles River Laboratories (CRL) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.72 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-06 08:30:23
Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients for its drug discovery and development services.
Sentiment: Positive
Publish Date: 2024-10-30 11:07:36
Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment: Positive
Publish Date: 2024-10-29 13:10:53
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sentiment: Neutral
Publish Date: 2024-10-22 10:30:39
Growth across all businesses within the Manufacturing segment is likely to have contributed to Charles River's Q3 revenues, offset by lower biopharmaceutical demand.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
